Medicus Pharma

Showing 3 posts of 3 posts found.

Medicus Pharma’s Teverelix shows positive efficacy and safety in premenopausal women

January 13, 2026
Research and Development Endocrinology, Medicus Pharma, Teverelix

Medicus Pharma’s Teverelix has demonstrated long-lasting hormone suppression, as well as a favourable safety profile, in new study data. Teverelix …

Medicus Pharma appoints Carolyn Bonner as CFO

December 4, 2025
Medicus Pharma, chief financial officer

Medicus Pharma has announced the appointment of Carolyn Bonner as Chief Financial Officer (CFO) in addition to her role as …

Medicus Pharma shares updates on basal cell carcinoma trials

December 2, 2025
Research and Development Medicus Pharma, Oncology

Medicus Pharma has announced updates on the progress of SKNJCT-003 and SKNJCT-004, its clinical trials studying the efficacy of a …

The Gateway to Local Adoption Series

Latest content